These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 29049861)

  • 1. Mifepristone-misoprostol for menstrual regulation in public sector facilities in Bangladesh.
    Alam A; Lotarevich T; Das TR; Reichenbach L; Bracken H
    Int J Gynaecol Obstet; 2018 Feb; 140(2):205-210. PubMed ID: 29049861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceptability and feasibility of mifepristone-misoprostol for menstrual regulation in Bangladesh.
    Alam A; Bracken H; Johnston HB; Raghavan S; Islam N; Winikoff B; Reichenbach L
    Int Perspect Sex Reprod Health; 2013 Jun; 39(2):79-87. PubMed ID: 23895884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and acceptability of a mifepristone-misoprostol combined regimen for early induced abortion among women in Mexico City.
    Peña M; Dzuba IG; Smith PS; Mendoza LJ; Bousiéguez M; Martínez ML; Polanco RR; Villalón AE; Winikoff B
    Int J Gynaecol Obstet; 2014 Oct; 127(1):82-5. PubMed ID: 24957534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Once-a-month treatment with a combination of mifepristone and the prostaglandin analogue misoprostol.
    Swahn ML; Bygdeman M; Chen JK; Gemzell-Danielsson K; Song S; Yang QY; Yang PJ; Qian ML; Chang WF
    Hum Reprod; 1999 Feb; 14(2):485-8. PubMed ID: 10099999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
    Guest J; Chien PF; Thomson MA; Kosseim ML
    BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acceptability and feasibility of the use of 400 μg of sublingual misoprostol after mifepristone for medical abortion up to 63 days since the last menstrual period: evidence from Uzbekistan.
    Raghavan S; Tsereteli T; Kamilov A; Kurbanbekova D; Yusupov D; Kasimova F; Jymagylova D; Winikoff B
    Eur J Contracept Reprod Health Care; 2013 Apr; 18(2):104-11. PubMed ID: 23387475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of misoprostol-only and combined mifepristone-misoprostol regimens for home-based early medical abortion in Tunisia and Vietnam.
    Blum J; Raghavan S; Dabash R; Ngoc Nt; Chelli H; Hajri S; Conkling K; Winikoff B
    Int J Gynaecol Obstet; 2012 Aug; 118(2):166-71. PubMed ID: 22682768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mifepristone followed by home administration of buccal misoprostol for medical abortion up to 70 days of amenorrhoea in a general practice in Curaçao.
    Boersma AA; Meyboom-de Jong B; Kleiverda G
    Eur J Contracept Reprod Health Care; 2011 Apr; 16(2):61-6. PubMed ID: 21303309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acceptability and feasibility of medical abortion with mifepristone and misoprostol in Nigeria.
    Okonofua F; Shittu O; Shochet T; Diop A; Winikoff B
    Int J Gynaecol Obstet; 2014 Apr; 125(1):49-52. PubMed ID: 24507887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety, efficacy and acceptability of outpatient mifepristone-misoprostol medical abortion through 70 days since last menstrual period in public sector facilities in Mexico City.
    Sanhueza Smith P; Peña M; Dzuba IG; García Martinez ML; Aranguré Peraza AG; Bousiéguez M; Shochet T; Winikoff B
    Reprod Health Matters; 2015 Feb; 22(44 Suppl 1):75-82. PubMed ID: 25702071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind randomized controlled trial of mifepristone or placebo before buccal misoprostol for abortion at 14-21 weeks of pregnancy.
    Dabash R; Chelli H; Hajri S; Shochet T; Raghavan S; Winikoff B
    Int J Gynaecol Obstet; 2015 Jul; 130(1):40-4. PubMed ID: 25896965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot study of mifepristone and misoprostol administered at the same time for abortion in women with gestation from 50 to 63 days.
    Schreiber CA; Creinin MD; Harwood B; Murthy AS
    Contraception; 2005 Jun; 71(6):447-50. PubMed ID: 15914135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized trial of mifepristone and buccal or vaginal misoprostol for abortion through 56 days of last menstrual period.
    Middleton T; Schaff E; Fielding SL; Scahill M; Shannon C; Westheimer E; Wilkinson T; Winikoff B
    Contraception; 2005 Nov; 72(5):328-32. PubMed ID: 16246656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility and effectiveness of unintended pregnancy prevention with low-dose mifepristone combined with misoprostol before expected menstruation.
    Li CL; Chen DJ; Deng YF; Song LP; Mo XT; Liu KJ
    Hum Reprod; 2015 Dec; 30(12):2794-801. PubMed ID: 26405260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical Preparation Before Dilation and Evacuation Using Adjunctive Misoprostol or Mifepristone Compared With Overnight Osmotic Dilators Alone: A Randomized Controlled Trial.
    Goldberg AB; Fortin JA; Drey EA; Dean G; Lichtenberg ES; Bednarek PH; Chen BA; Dutton C; McKetta S; Maurer R; Winikoff B; Fitzmaurice GM
    Obstet Gynecol; 2015 Sep; 126(3):599-609. PubMed ID: 26196084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of mifepristone combination with misoprostol and misoprostol alone in the management of intrauterine death: condensation - misoprostol and mifepristone combination is more effective than misoprostol alone in the management of intrauterine death.
    Sharma D; Singhal SR; Poonam ; Paul A; Kunika
    Taiwan J Obstet Gynecol; 2011 Sep; 50(3):322-5. PubMed ID: 22030047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial of oral versus sublingual misoprostol 24 h after mifepristone for medical abortion.
    Dahiya K; Mann S; Nanda S
    Arch Gynecol Obstet; 2011 Jul; 284(1):59-63. PubMed ID: 20652288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acceptability and feasibility of 400 μg buccal misoprostol after 200 mg mifepristone for early medical abortion in Georgia.
    Tsereteli T; Chong E; Louie K; Bokhua Z; Winikoff B
    Eur J Contracept Reprod Health Care; 2016 Oct; 21(5):367-71. PubMed ID: 27449873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mifepristone followed in 24 hours to 48 hours by misoprostol for late first-trimester abortion.
    Bracken H; Ngoc NT; Schaff E; Coyaji K; Ambardekar S; Westheimer E; Winikoff B
    Obstet Gynecol; 2007 Apr; 109(4):895-901. PubMed ID: 17400851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized controlled trial of different buccal misoprostol doses in mifepristone medical abortion.
    Chong E; Tsereteli T; Nguyen NN; Winikoff B
    Contraception; 2012 Sep; 86(3):251-6. PubMed ID: 22305917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.